Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancer

被引:175
作者
Millar, DS
Ow, KK
Paul, CL
Russell, PJ
Molloy, PL
Clark, SJ
机构
[1] CSIRO, Div Mol Sci, Sydney Lab, N Ryde, NSW 1670, Australia
[2] Royal Prince Alfred Hosp, Kanematsu Labs, Camperdown, NSW 2050, Australia
[3] Prince Wales Hosp, Oncol Res Ctr, Randwick, NSW 2031, Australia
关键词
DNA methylation; bisulphite genomic sequencing; GSTP1; prostate cancer;
D O I
10.1038/sj.onc.1202415
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glutathione-S-Transferases (GSTs) comprise a family of isoenzymes that provide protection to mammalian cells against electrophilic metabolites of carcinogens and reactive oxygen species. Previous studies have shown that the CpG-rich promoter region of the pi-class gene GSTP1 is methylated at single restriction sites in the majority of prostate cancers, In order to understand the nature of abnormal methylation of the GSTP1 gene in prostate cancer we undertook a detailed analysis of methylation at 131 CpG sites spanning the promoter and body of the gene. Our results show that DNA methylation is not confined to specific CpG sites in the promoter region of the GSTP1 gene but is extensive throughout the CpG island in prostate cancer cells. Furthermore we found that both alleles are abnormally methylated in this region. In normal prostate tissue, the entire CpG island was unmethylated, but extensive methylation was found outside the island in the body of the gene. Loss of GSTP1 expression correlated with DNA methylation of the CpG island in both prostate cancer cell lines and cancer tissues whereas methylation outside the CpG island in normal prostate tissue appeared to have no effect on gene expression.
引用
收藏
页码:1313 / 1324
页数:12
相关论文
共 43 条
[31]  
Schmutte C, 1996, CANCER RES, V56, P2375
[32]   Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search [J].
Smith, JR ;
Freije, D ;
Carpten, JD ;
Gronberg, H ;
Xu, JF ;
Isaacs, SD ;
Brownstein, MJ ;
Bova, GS ;
Guo, H ;
Bujnovszky, P ;
Nusskern, DR ;
Damber, JE ;
Bergh, A ;
Emanuelsson, M ;
Kallioniemi, OP ;
WalkerDaniels, J ;
BaileyWilson, JE ;
Beaty, TH ;
Meyers, DA ;
Walsh, PC ;
Collins, FS ;
Trent, JM ;
Isaacs, WB .
SCIENCE, 1996, 274 (5291) :1371-1374
[33]  
Stirzaker C, 1997, CANCER RES, V57, P2229
[34]   Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1 [J].
Stoger, R ;
Kajimura, TM ;
Brown, WT ;
Laird, CD .
HUMAN MOLECULAR GENETICS, 1997, 6 (11) :1791-1801
[35]   METHYLATION ANALYSIS BY GENOMIC SEQUENCING OF 5' REGION OF MOUSE PGK-1 GENE AND A CAUTIONARY NOTE CONCERNING THE METHOD [J].
TOMMASI, S ;
LEBON, JM ;
RIGGS, AD ;
SINGERSAM, J .
SOMATIC CELL AND MOLECULAR GENETICS, 1993, 19 (06) :529-541
[36]   ESTABLISHMENT OF DENOVO DNA METHYLATION PATTERNS - TRANSCRIPTION FACTOR BINDING AND DEOXYCYTIDINE METHYLATION AT CPG AND NON-CPG SEQUENCES IN AN INTEGRATED ADENOVIRUS PROMOTER [J].
TOTH, M ;
MULLER, U ;
DOERFLER, W .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 214 (03) :673-683
[37]  
Wang X, 1997, CLIN CANCER RES, V3, P111
[38]   Bisulfite sequencing in preimplantation embryos:: DNA methylation profile of the upstream region of the mouse imprinted H19 gene [J].
Warnecke, PM ;
Mann, JR ;
Frommer, M ;
Clark, SJ .
GENOMICS, 1998, 51 (02) :182-190
[39]   Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA [J].
Warnecke, PM ;
Stirzaker, C ;
Melki, JR ;
Millar, DS ;
Paul, CL ;
Clark, SJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (21) :4422-4426
[40]  
Warnecke PM, 1998, DEV GENET, V22, P111, DOI 10.1002/(SICI)1520-6408(1998)22:2&lt